Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Consumption of Non-Antibacterial Drugs May Have Negative Impact on Helicobacter Pylori Colonization in the Stomach Publisher



Atif AN1, 2 ; Hatefi A1 ; Arven A1, 3 ; Foroumadi A4 ; Kadkhodaei S1 ; Sadjadi A5 ; Siavoshi F1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Microbiology, School of Biology, University College of Sciences, University of Tehran, Tehran, Iran
  2. 2. Department of Biology, Faculty of Sciences, Nangarhar University, Jalalabad, Afghanistan
  3. 3. Department of Biology, Faculty of Education, Daykundi University, Nilli, Afghanistan
  4. 4. Department of Medicinal Chemistry, Faculty of Pharmacy and Drug Design & Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Heliyon Published:2024


Abstract

Background: Nineteen non-antibacterials were examined to show that their consumption for treatment of other diseases may inhibit Helicobacter pylori. Four antibiotics were used for comparison. Materials and methods: Agar dilution method was used to examine the susceptibility of 20 H. pylori isolates to 4 antibiotics; metronidazole (MTZ), clarithromycin (CLR), amoxicillin (AMX), tetracycline (TET) and 19 non-antibacterials; proton pump inhibitors (PPIs), H2-blockers, bismuth subsalicylate (BSS), antifungals, statins, acetaminophen (ACE), aspirin (ASA), B-vitamins (B-Vits; Vit B1, Vit B6 and Vit Bcomplex) and vitamin C (Vit C). Blood agar plates were prepared with different concentrations of drugs and spot-inoculated with bacterial suspensions. Plates were incubated at 37 °C under microaerobic conditions and examined after 3–5 days. The isolate #20 that was mucoid and resistant to 19 drugs, including MTZ and SMV was tested against combined MTZ (8 μg/mL) and SMV (100 μg/mL). Results were analyzed statistically. Results: Minimum inhibitory concentrations (MICs, μg/mL) of drugs and the frequency of susceptible H. pylori were determined as MTZ (8, 80%), CLR (2, 90%), AMX (1, 100%), TET (0.5, 70%), PPIs (8–128, 80%), H2-blockers (2000–8000, 75–80%), BSS (15, 85%), antifungals (64–256, 30–80%), statins (100–250, 35–90%), ACE (40, 75%), ASA (800, 75%), B-Vits (5000–20000, 80–100%) and Vit C (2048, 85%). Susceptibility of H. pylori isolates to 16 out of 19 non-antimicrobials (75–100%) was almost similar to those of antibiotics (70–100%) (P-value >0.05). The highest susceptibility rate (100%) belonged to Vit B1, Vit B6 and AMX. Out of 20 H. pylori isolates, 17 (85%) were susceptible to ≥13 non-antimicrobials and 3 (15%) were susceptible to < 13 (P-value <0.05). Mucoid H. pylori showed susceptibility to combination of MTZ and SMV. Conclusions: Most of non-antibacterials inhibited H. pylori isolates, similar to antibiotics but their MICs exceeded those of antibiotics and their plasma concentrations. At low plasma concentration, non-antimicrobials may act as weak antibacterials, antibiotic adjuvants and immunostimulators. © 2024 The Authors